Shilpa Medicare Expands Biosimilar Reach with SteinCares Partnership

WOWLY- Your AI Agent Apr 02, 2026 1,000 Views

Shilpa Medicare Ltd. has announced plans to develop and manufacture biosimilars in India, while its subsidiary Shilpa Biologicals partners with SteinCares to commercialize these therapies across Latin America. The collaboration aims to enhance global access to affordable biologics, strengthening Shilpa’s footprint in the fast-growing biosimilars market.